Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Comparison of intraoperative versus intraoperative plus postoperative hemoadsorption therapy in cardiac surgery patients with endocarditis.

Kühne LU, Binczyk R, Rieß FC.

Int J Artif Organs. 2019 Apr;42(4):194-200. doi: 10.1177/0391398819831301. Epub 2019 Feb 25.

PMID:
30803290
2.

Five-Year Outcome After Off-Pump or On-Pump Coronary Artery Bypass Grafting in Elderly Patients.

Diegeler A, Börgermann J, Kappert U, Hilker M, Doenst T, Böning A, Albert M, Färber G, Holzhey D, Conradi L, Rieß FC, Veeckmann P, Minorics C, Zacher M, Reents W.

Circulation. 2019 Apr 16;139(16):1865-1871. doi: 10.1161/CIRCULATIONAHA.118.035857.

PMID:
30732456
3.

Six-Month Performance of a 3-Dimensional Annuloplasty Ring for Repair of Functional Tricuspid Regurgitation.

Guenzinger R, Lange RS, Rieß FC, Hanke T, Bischoff N, Obadia JF, Sahar G, Bitran D, Roberts H Jr, Li S, Bolling SF.

Thorac Cardiovasc Surg. 2018 Nov 16. doi: 10.1055/s-0038-1673665. [Epub ahead of print]

PMID:
30452076
4.

[Operative risk of geriatric patients in cardiac surgery].

Frilling B, von Renteln-Kruse W, Rösler A, Rieß FC.

Z Gerontol Geriatr. 2018 Jun;51(4):399-403. doi: 10.1007/s00391-018-1406-8. Epub 2018 May 23. Review. German.

PMID:
29796869
5.

Off-Pump Coronary Artery Bypass Grafting and Stroke-Exploratory Analysis of the GOPCABE Trial and Methodological Considerations.

Reents W, Zacher M, Boergermann J, Kappert U, Hilker M, Färber G, Albert M, Holzhey D, Conradi L, Riess FC, Veeckman P, Strauch JT, Diegeler A, Böning A.

Thorac Cardiovasc Surg. 2018 Sep;66(6):464-469. doi: 10.1055/s-0038-1636936. Epub 2018 Mar 22.

PMID:
29566406
6.

Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli ≥26 mm.

Eitan A, Witt J, Stripling J, Haselbach T, Rieß FC, Schofer J.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1374-1379. doi: 10.1002/ccd.27588. Epub 2018 Mar 9.

PMID:
29521464
7.

Long-Term Outcomes of the Mosaic Bioprosthesis.

Rieß FC, Fradet G, Lavoie A, Legget M.

Ann Thorac Surg. 2018 Mar;105(3):763-769. doi: 10.1016/j.athoracsur.2017.09.053. Epub 2017 Dec 28.

PMID:
29289363
8.

Complete arterial revascularization using bilateral internal mammary artery in T-graft technique for multivessel coronary artery disease in on- or off-pump approach: does gender lose its historical impact on clinical outcome?

Rieß FC, Behrendt CA, Amin W, Heller S, Hansen L, Winkel S, Stripling J, Rieß HC.

Eur J Cardiothorac Surg. 2017 Nov 1;52(5):917-923. doi: 10.1093/ejcts/ezx287.

PMID:
29029008
9.

Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair.

Yzeiraj E, Bijuklic K, Tiburtius C, Witt J, Krause K, Steude J, Hansen L, Rieß FC, Schofer J.

EuroIntervention. 2017 Feb 3;12(15):e1817-e1824. doi: 10.4244/EIJ-D-16-00909.

10.

On-Pump versus Off-Pump Complete Arterial Revascularization Using Bilateral Internal Mammary Arteries and the T-Graft Technique: Clinical and Angiographic Results for 3,445 Patients in 13 Years of Follow-Up.

Riess FC, Heller S, Cramer E, Awwad N, Amin W, Hansen L, Lehmann C, Schofer J, Stripling J, Winkel S, Kremer P.

Cardiology. 2017;136(3):170-179. doi: 10.1159/000448428. Epub 2016 Oct 4.

PMID:
27698326
11.

Transfemoral Tricuspid Valve Repair Using a Percutaneous Mitral Valve Repair System.

Schofer J, Tiburtius C, Hammerstingl C, Dickhaut PO, Witt J, Hansen L, Riess FC, Bijuklic K.

J Am Coll Cardiol. 2016 Feb 23;67(7):889-90. doi: 10.1016/j.jacc.2015.11.047. No abstract available.

12.

Transfemoral Implantation of a Fully Repositionable and Retrievable Transcatheter Valve for Noncalcified Pure Aortic Regurgitation.

Schofer J, Nietlispach F, Bijuklic K, Colombo A, Gatto F, De Marco F, Mangieri A, Hansen L, Bruschi G, Ruparelia N, Rieß FC, Maisano F, Latib A.

JACC Cardiovasc Interv. 2015 Dec 21;8(14):1842-9. doi: 10.1016/j.jcin.2015.08.022. Epub 2015 Nov 18.

13.

First-in-man transcatheter mitral valve-in-ring implantation with a repositionable and retrievable aortic valve prosthesis.

Latib A, Ruparelia N, Bijuklic K, De Marco F, Gatto F, Hansen L, Ozbek C, Greilach P, Bruschi G, Rieß FC, Alfieri O, Colombo A, Schofer J.

EuroIntervention. 2016 Feb;11(10):1148-52. doi: 10.4244/EIJY15M11_02.

14.

Increased Risk of Cerebral Embolization After Implantation of a Balloon-Expandable Aortic Valve Without Prior Balloon Valvuloplasty.

Bijuklic K, Haselbach T, Witt J, Krause K, Hansen L, Gehrckens R, Rieß FC, Schofer J.

JACC Cardiovasc Interv. 2015 Oct;8(12):1608-13. doi: 10.1016/j.jcin.2015.07.013. Epub 2015 Sep 17.

15.

Off-pump versus on-pump coronary-artery bypass grafting in elderly patients.

Diegeler A, Börgermann J, Kappert U, Breuer M, Böning A, Ursulescu A, Rastan A, Holzhey D, Treede H, Rieß FC, Veeckmann P, Asfoor A, Reents W, Zacher M, Hilker M; GOPCABE Study Group.

N Engl J Med. 2013 Mar 28;368(13):1189-98. doi: 10.1056/NEJMoa1211666. Epub 2013 Mar 11.

16.

Fibrous cyst arising from the cordae tendiniae of the mitral valve.

Riess FC, Löning T, Danne M.

Ann Thorac Surg. 2012 Apr;93(4):1319. doi: 10.1016/j.athoracsur.2011.07.013. No abstract available.

PMID:
22450091
17.

Medtronic Mosaic porcine bioprosthesis: assessment of 12-year performance.

Jamieson WR, Riess FC, Raudkivi PJ, Metras J, Busse EF, Goldstein J, Fradet GJ.

J Thorac Cardiovasc Surg. 2011 Aug;142(2):302-7.e2. doi: 10.1016/j.jtcvs.2010.08.090. Epub 2011 Feb 1.

18.

Aortic valve replacement after transapical valve-in-valve implantation.

Silva D, Stripling JH, Hansen L, Riess FC.

Ann Thorac Surg. 2011 Jan;91(1):e5-7. doi: 10.1016/j.athoracsur.2010.08.065.

PMID:
21172473
19.

The Mosaic porcine bioprosthesis: role of age on clinical performance in aortic position.

Riess FC, Bader R, Cramer E, Hansen L, Schiffelers S, Wallrath J, Wahl G.

J Thorac Cardiovasc Surg. 2011 Jun;141(6):1440-8.e1. doi: 10.1016/j.jtcvs.2010.05.052. Epub 2010 Sep 20.

20.

Evaluation of operative risk in elderly patients undergoing aortic valve replacement: the predictive value of operative risk scores.

Frilling B, von Renteln-Kruse W, Riess FC.

Cardiology. 2010;116(3):213-8. doi: 10.1159/000319703. Epub 2010 Aug 6.

PMID:
20689278
21.

Geriatric Perspective.

Riess FC, von-Renteln Kruse W, Frilling B.

Dtsch Arztebl Int. 2009 Oct;106(42):693-4; author reply 694. doi: 10.3238/arztebl.2009.0693b. Epub 2009 Oct 16. No abstract available.

22.

Factors influencing survival and postoperative quality of life after mitral valve reconstruction.

Hansen L, Winkel S, Kuhr J, Bader R, Bleese N, Riess FC.

Eur J Cardiothorac Surg. 2010 Mar;37(3):635-44. doi: 10.1016/j.ejcts.2009.07.044. Epub 2009 Sep 12.

PMID:
19748791
23.

Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years.

Riess FC, Cramer E, Hansen L, Schiffelers S, Wahl G, Wallrath J, Winkel S, Kremer P.

Eur J Cardiothorac Surg. 2010 Jan;37(1):145-53. doi: 10.1016/j.ejcts.2009.04.073. Epub 2009 Aug 19.

PMID:
19695889
24.

Desmoteplase in acute massive pulmonary thromboembolism.

Tebbe U, Bramlage P, Graf A, Lechleitner P, Bode C, Riess FC, Clemens N, Al-Rawi Y, Konstantinides S, Goldhaber SZ.

Thromb Haemost. 2009 Mar;101(3):557-62.

PMID:
19277420
25.

Preexisting atrial fibrillation as predictor for late-time mortality in patients with end-stage renal disease undergoing cardiac surgery--a multicenter study.

Schönburg M, Ziegelhoeffer T, Weinbrenner F, Bechtel M, Detter C, Krabatsch T, Osswald B, Riess FC, Scholz F, Stamm C, Sievers HH, Bartels C.

Thorac Cardiovasc Surg. 2008 Apr;56(3):128-32. doi: 10.1055/s-2007-989432.

PMID:
18365969
26.

Cardiac surgery in patients on dialysis: decreased 30-day mortality, unchanged overall survival.

Bechtel JF, Detter C, Fischlein T, Krabatsch T, Osswald BR, Riess FC, Scholz F, Schönburg M, Stamm C, Sievers HH, Bartels C.

Ann Thorac Surg. 2008 Jan;85(1):147-53.

PMID:
18154800
27.

Structural valve failure with every beat regurgitation observed using the Medtronic Advantage aortic valve.

Hansen L, Danne M, Hoffmann B, Riess FC.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1344-5. No abstract available.

28.

Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.

Riess FC, Poetzsch B, Madlener K, Cramer E, Doll KN, Doll S, Lorke DE, Kormann J, Mueller-Berghaus G.

Thorac Cardiovasc Surg. 2007 Jun;55(4):233-8.

PMID:
17546553
29.

Hemodynamic performance of the Medtronic Mosaic porcine bioprosthesis up to ten years.

Riess FC, Bader R, Cramer E, Hansen L, Kleijnen B, Wahl G, Wallrath J, Winkel S, Bleese N.

Ann Thorac Surg. 2007 Apr;83(4):1310-8.

PMID:
17383332
30.
31.
32.

Anticoagulation management and cardiac surgery in patients with heparin-induced thrombocytopenia.

Riess FC.

Semin Thorac Cardiovasc Surg. 2005 Spring;17(1):85-96. Review.

PMID:
16104366
33.

Pulmonary embolism after cesarian section due to heparin-induced thrombocytopenia despite normal platelet count.

Riess FC, Gross A, Budde U.

Thorac Cardiovasc Surg. 2005 Aug;53(4):255-7.

PMID:
16037876
34.

Congenital fistula between the left internal mammary artery (LIMA) and the pulmonary artery: cause of LIMA bypass occlusion?

Riess FC, Lehmann C, Loewer C, Schofer J, Bleese N.

Heart Surg Forum. 2004;7(5):E403-4.

PMID:
15799912
35.
36.

A steel band in addition to 8 wire cerclages reduces the risk of sternal dehiscence after median sternotomy.

Riess FC, Awwad N, Hoffmann B, Bader R, Helmold HY, Loewer C, Riess AG, Bleese N.

Heart Surg Forum. 2004;7(6):387-92.

PMID:
15769705
37.

Off-Pump Arterial Revascularization Using a New Reusable Device for Coronary Occlusion and Local Stabilization.

Riess FC, Bader R, Hoffmann B, Kormann J, Riess AG, Stripling J, Bleese N.

Heart Surg Forum. 2004 Jan 1;7(1):107-112.

PMID:
14980858
38.

Clinical experience with the CorLink device for proximal anastomosis of the saphenous vein to the aorta: a clinical, prospective, and randomized study.

Riess FC, Helmold H, Hilfer I, Bader R, Stripling J, Loewer C, Wesner F, Bleese N.

Heart Surg Forum. 2002;5(4):345-53.

PMID:
12538116
39.

Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up.

Riess FC, Bader R, Kremer P, Kühn C, Kormann J, Mathey D, Moshar S, Tuebler T, Bleese N, Schofer J.

Ann Thorac Surg. 2002 Jun;73(6):1849-55.

PMID:
12078780
40.

Correction of congenital heart defects and mitral valve operations using limited anterolateral thoracotomy.

Riess FC, Moshar S, Bader R, Hoffmann B, Löwer C, Bleese N.

Heart Surg Forum. 2001;4(1):34-9.

PMID:
11502495
41.

Clinical outcome of patients with and without renal impairment undergoing a minimally invasive LIMA-to-LAD bypass operation.

Riess FC, Moshar S, Bader R, Schofer J, Löwer C, Kremer P, Bleese N.

Heart Surg Forum. 2000;3(4):313-8.

PMID:
11178293
42.

Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermia.

Riess FC, Fiege M, Moshar S, Bergmann H, Bleese N, Kormann J, Weisshorn R, Wappler F.

Anesthesiology. 2001 Feb;94(2):355-7. No abstract available.

PMID:
11176102
43.

Recombinant hirudin as anticoagulant during cardiopulmonary bypass.

Riess FC, Kormann J, Poetzsch B.

Anesthesiology. 2000 Dec;93(6):1551-2. No abstract available.

PMID:
11149460
44.

A new method for coronary occlusion and local stabilization during minimally invasive LIMA-to-LAD-bypass.

Riess FC, Bleese N, Riess AG.

Eur J Cardiothorac Surg. 1999 Feb;15(2):206-8.

PMID:
10219556
45.

Prevention of potential complications after minimal access aortic valve replacement.

Riess FC, Löwer C, Bleese N.

Ann Thorac Surg. 1998 Nov;66(5):1866. No abstract available.

PMID:
9875826
46.

Beating heart operations including hybrid revascularization: initial experiences.

Riess FC, Schofer J, Kremer P, Riess AG, Bergmann H, Moshar S, Mathey D, Bleese N.

Ann Thorac Surg. 1998 Sep;66(3):1076-81.

PMID:
9769007
47.

Short-term neuropsychologic differences after normothermic versus hypothermic cardiopulmonary bypass.

Buschbeck D, Riess FC, Dobritzsch B, Dahme B, Bleese N.

J Thorac Cardiovasc Surg. 1998 Aug;116(2):350-3. No abstract available.

48.

Recombinant hirudin is a heparin alternative in cardiac surgery.

Riess FC, Bleese N, Kormann J, Pötzsch B, Madlener K, Müller-Berghaus G, Greinacher A.

J Cardiothorac Vasc Anesth. 1997 Jun;11(4):538-9. No abstract available.

PMID:
9188012
49.

Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.

Riess FC, Pötzsch B, Behr I, Jäger K, Rössing R, Bleese N, Schaper W, Müller-Berghaus G.

Eur J Cardiothorac Surg. 1997 Apr;11(4):739-45.

PMID:
9151047
50.

A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery.

Riess FC, Pötzsch B, Bader R, Bleese N, Greinacher A, Löwer C, Madlener K, Müller-Berghaus G.

Eur J Cardiothorac Surg. 1996;10(5):386-8. No abstract available.

PMID:
8737698

Supplemental Content

Loading ...
Support Center